Akebia Therapeutics recalls
Akebia Therapeutics has 2 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 24 Feb 2021. The most frequent reason is potency & assay.
Total recalls2since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 24 Feb 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why akebia therapeutics is recalled
By year
All akebia therapeutics recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Auryxia (ferric citrate) tablets, 210 mg* recalled | Akebia Therapeutics | Potency & Assay | Nationwide |
| Drug | CLASS II | Auryxia (ferric citrate) tablets, 210 mg recalled by Akebia TherapeuticsAuryxia | Akebia Therapeutics | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.